466 related articles for article (PubMed ID: 16959435)
1. Pathological findings of uterine leiomyomas and adenomyosis following uterine artery embolization.
Dundr P; Mára M; Masková J; Fucíková Z; Povỳsil C; Tvrdík D
Pathol Res Pract; 2006; 202(10):721-9. PubMed ID: 16959435
[TBL] [Abstract][Full Text] [Related]
2. Uterine artery embolization for symptomatic adenomyosis with or without uterine leiomyomas with the use of calibrated tris-acryl gelatin microspheres: midterm clinical and MR imaging follow-up.
Lohle PN; De Vries J; Klazen CA; Boekkooi PF; Vervest HA; Smeets AJ; Lampmann LE; Kroencke TJ
J Vasc Interv Radiol; 2007 Jul; 18(7):835-41. PubMed ID: 17609441
[TBL] [Abstract][Full Text] [Related]
3. Polyvinyl alcohol particles and tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: results of a randomized comparative study.
Spies JB; Allison S; Flick P; McCullough M; Sterbis K; Cramp M; Bruno J; Jha R
J Vasc Interv Radiol; 2004 Aug; 15(8):793-800. PubMed ID: 15297582
[TBL] [Abstract][Full Text] [Related]
4. Leiomyoma infarction after uterine artery embolization: a prospective randomized study comparing tris-acryl gelatin microspheres versus polyvinyl alcohol microspheres.
Siskin GP; Beck A; Schuster M; Mandato K; Englander M; Herr A
J Vasc Interv Radiol; 2008 Jan; 19(1):58-65. PubMed ID: 18192468
[TBL] [Abstract][Full Text] [Related]
5. Comparison of clinical outcomes of tris-acryl microspheres versus polyvinyl alcohol microspheres for uterine artery embolization for leiomyomas: results of a randomized trial.
Yu SC; Lok I; Ho SS; Tong MM; Hui JW
J Vasc Interv Radiol; 2011 Sep; 22(9):1229-35. PubMed ID: 21802314
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy of the embolic agents acrylamido polyvinyl alcohol microspheres and tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: a prospective randomized controlled trial.
Worthington-Kirsch RL; Siskin GP; Hegener P; Chesnick R
Cardiovasc Intervent Radiol; 2011 Jun; 34(3):493-501. PubMed ID: 21127866
[TBL] [Abstract][Full Text] [Related]
7. Comparison of MRI outcomes of uterine artery embolization for uterine leiomyoma using tris-acryl gelatin microspheres, polyvinyl alcohol spheres, and polyvinyl alcohol particles.
Galvez JA; McCarthy S; Weinreb J; Zelterman D; White RI; Pollak J; Tal MG
J Comput Assist Tomogr; 2008; 32(3):356-61. PubMed ID: 18520537
[TBL] [Abstract][Full Text] [Related]
8. Polyvinyl alcohol particles versus tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas.
Pelage JP
J Vasc Interv Radiol; 2004 Aug; 15(8):789-91. PubMed ID: 15297581
[No Abstract] [Full Text] [Related]
9. Spherical versus conventional polyvinyl alcohol particles for uterine artery embolization.
Rasuli P; Hammond I; Al-Mutairi B; French GJ; Aquino J; Hadziomerovic A; Goulet S; Jolly EE
J Vasc Interv Radiol; 2008 Jan; 19(1):42-6. PubMed ID: 18192466
[TBL] [Abstract][Full Text] [Related]
10. Adenomyosis: MRI of the uterus treated with uterine artery embolization.
Jha RC; Takahama J; Imaoka I; Korangy SJ; Spies JB; Cooper C; Ascher SM
AJR Am J Roentgenol; 2003 Sep; 181(3):851-6. PubMed ID: 12933493
[TBL] [Abstract][Full Text] [Related]
11. Pathologic features of uteri and leiomyomas following uterine artery embolization for leiomyomas.
Colgan TJ; Pron G; Mocarski EJ; Bennett JD; Asch MR; Common A
Am J Surg Pathol; 2003 Feb; 27(2):167-77. PubMed ID: 12548162
[TBL] [Abstract][Full Text] [Related]
12. Uterine arterial embolization with tris-acryl gelatin microspheres: a histopathologic evaluation.
Weichert W; Denkert C; Gauruder-Burmester A; Kurzeja R; Hamm B; Dietel M; Kroencke TJ
Am J Surg Pathol; 2005 Jul; 29(7):955-61. PubMed ID: 15958862
[TBL] [Abstract][Full Text] [Related]
13. Spherical polyvinyl alcohol versus tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: results of a limited randomized comparative study.
Spies JB; Allison S; Flick P; Cramp M; Bruno J; Jha RC; Ascher SA
J Vasc Interv Radiol; 2005 Nov; 16(11):1431-7. PubMed ID: 16319148
[TBL] [Abstract][Full Text] [Related]
14. Uterine artery embolization of leiomyomas with trisacryl gelatin microspheres (TGM): pathologic features and comparison with polyvinyl alcohol emboli.
Chiesa AG; Hart WR
Int J Gynecol Pathol; 2004 Oct; 23(4):386-92. PubMed ID: 15381909
[TBL] [Abstract][Full Text] [Related]
15. Acrylamido polyvinyl alcohol microspheres for uterine artery embolization: 12-month clinical and MR imaging results.
Kroencke TJ; Scheurig C; Lampmann LE; Boekkooi PF; Kissner L; Kluner C; Weichert W; Hamm B; Lohle PN
J Vasc Interv Radiol; 2008 Jan; 19(1):47-57. PubMed ID: 18192467
[TBL] [Abstract][Full Text] [Related]
16. Uterine artery embolization with trisacryl gelatin microspheres in women treated for leiomyomas: a clinicopathologic analysis of alterations in gynecologic surgical specimens.
Maleki Z; Kim HS; Thonse VR; Judson K; Vinh TN; Vang R
Int J Gynecol Pathol; 2010 May; 29(3):260-8. PubMed ID: 20407327
[TBL] [Abstract][Full Text] [Related]
17. A prospective multicenter comparative study between myomectomy and uterine artery embolization with polyvinyl alcohol microspheres: long-term clinical outcomes in patients with symptomatic uterine fibroids.
Siskin GP; Shlansky-Goldberg RD; Goodwin SC; Sterling K; Lipman JC; Nosher JL; Worthington-Kirsch RL; Chambers TP;
J Vasc Interv Radiol; 2006 Aug; 17(8):1287-95. PubMed ID: 16923975
[TBL] [Abstract][Full Text] [Related]
18. Comparison of particle penetration with non-spherical polyvinyl alcohol versus trisacryl gelatin microspheres in women undergoing premyomectomy uterine artery embolization.
Chua GC; Wilsher M; Young MP; Manyonda I; Morgan R; Belli AM
Clin Radiol; 2005 Jan; 60(1):116-22. PubMed ID: 15642302
[TBL] [Abstract][Full Text] [Related]
19. Uterine artery embolization: current implications of embolic agent choice.
Ryu RK
J Vasc Interv Radiol; 2005 Nov; 16(11):1419-22. PubMed ID: 16319145
[No Abstract] [Full Text] [Related]
20. Uterine artery embolization to treat uterine adenomyosis with or without uterine leiomyomata: results of symptom control and health-related quality of life 40 months after treatment.
Froeling V; Scheurig-Muenkler C; Hamm B; Kroencke TJ
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):523-9. PubMed ID: 21850565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
